Inventor · disambiguated record
Yeming Wang
Also filed as: WANG YEMING
8 granted patents·4 pending applications·53 citations·filing 2000–2024
83Inventor score
Files withBEIJING TIDE PHARMACEUTICAL CO LTD10CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1SHANGHAI YUE LONG NON FERROUS1
Top patents by PatentIndex Score
12 records- 0195US11919918B2P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 5, 2024·6 cites·20 claims
- 0291US12180243B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 31, 2024·2 cites·74 claims
- 0389US11414444B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 16, 2022·5 cites·15 claims
- 0486US11453690B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 27, 2022·3 cites·50 claims
- 0580US12509479B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 0680US6605565B1Nanocrystal cerium zirconium composite oxide, its preparation and applicationSHANGHAI YUE LONG NON FERROUS·Filed 2000·Granted Aug 12, 2003·37 cites·13 claims
- 0779US2025066398A1Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0863US2025257086A1Egfr degradation agentBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0962US2025288535A1Instant nanoparticle composition and preparation method thereforCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2023·Application pending·0 cites
- 1046US2022306659A1Compound inhibiting and inducing degradation of egfr and alkBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1145US12410192B2Compound for inhibiting and inducing degradation of EGFR kinaseBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 9, 2025·0 cites·20 claims
- 1243US11905274B2Receptor inhibitors, pharmaceutical compositions comprising the same and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 20, 2024·0 cites·44 claims
Join the waitlist — get patent alerts
Get an alert when Yeming Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →